Medicine

An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.

A. Ashworth, S. Senan, D. Palma, M. Riquet, Y. Ahn, U. Ricardi, M. Congedo, D. Gomez, Gavin Wright, G. Melloni, M. Milano, C. Sole, T. D. De Pas, D. Carter, A. Warner, G. Rodrigues

2014.9.1Clinical Lung Cancer

DOI: 10.1016/j.cllc.2014.04.003

tlooto Summary

Significant OS differences were observed in oligometastatic patients stratified according to type of metastatic presentation, and N status, and this risk classification scheme is proposed to be used in guiding selection of patients for clinical trials of ablative treatment.

Abstract

Abstract is not available.

Citation format

ASHWORTH, A., et al. An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer. Clinical Lung Cancer, 2014, 15 5: 346–55.